Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
23 hedge funds and large institutions have $9.92M invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2021 Q4 according to their latest regulatory filings, with 23 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
+$278K |
| 2 |
BlackRock
New York
|
+$157K |
| 3 |
IAM
Ion Asset Management
Herzliya,
Israel
|
+$156K |
| 4 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
+$120K |
| 5 |
BAMCO Inc
New York
|
+$106K |
Top Sellers
CTV.WS Hedge Fund Activity: Q4 2021 in Review
23 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q4 2021, worth a combined $9.92M.
Buyers outnumbered sellers: 23 funds opened new CTV.WS positions and 0 closed out — a net gain of 23 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Senvest Management, opening a new position worth an estimated $278K.
- 23 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $9.92M of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q4 2021.
- 23 funds opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q4 2021 and 0 closed out, a net change of +23 holders.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q4 2021 was Senvest Management, an estimated $278K added.
Based on aggregated 13F filings for Q4 2021.